Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Krystal Biotech, Inc. | 1,427,159 | reported | 04 Mar 2026 | tx 262+763,992−1,263,969 |
| NEW RIVER PHARMACEUTICALS INC | 178,920 | reported | 25 Jan 2007 | tx 32+1,539,600−596,800 |
| PRECIGEN, INC. | 56,657 | reported | 29 Jan 2016 | tx 12+434,214−134,214 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 407 | 257.32 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 589 | 258.54 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 668 | 259.61 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 3,667 | 260.37 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 1,700 | 266.42 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 1,938 | 262.35 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 2,248 | 263.58 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 4,852 | 264.64 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 6,000 | 265.16 USD | |
| 04 Mar 2026 | SALE | Krystal Biotech, Inc. | 2,931 | 261.41 USD | |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 5,725 | 0.00 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 11,942 | 275.64 USD | |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 26,250 | 0.00 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 3,981 | 275.64 USD | |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 8,750 | 0.00 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 1,820 | 275.64 USD | |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 4,000 | 0.00 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 10,236 | 275.64 USD | |
| 27 Feb 2026 | TAX_WITHHOLDING | Krystal Biotech, Inc. | 2,605 | 275.64 USD | |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 22,500 | 0.00 USD | |
| 27 Feb 2026 | GRANT_AWARD | Krystal Biotech, Inc. | 7,256 | 0.00 USD | deriv |
| 27 Feb 2026 | GRANT_AWARD | Krystal Biotech, Inc. | 18,100 | 0.00 USD | deriv |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 4,000 | 0.00 USD | deriv |
| 27 Feb 2026 | EXERCISE | Krystal Biotech, Inc. | 22,500 | 0.00 USD | deriv |
| 27 Feb 2026 | GRANT_AWARD | Krystal Biotech, Inc. | 43,536 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 22 Sept 2017.